GENEXUS Trademark
GENEXUS is a USPTO trademark filed by Life Technologies Corporation. Status: Pending.
Prosecution Summary
Trademark Summary
The standard character mark GENEXUS covers apparatus and instruments for clinical and medical diagnosis in International Class 010, namely nucleic acid sequencers and synthesizers, genetic analyzers, and instruments for the preparation of nucleic acid samples; it also references U.S. classes 026, 039, and 044. Life Technologies Corporation, a Delaware corporation based in Carlsbad, California, owns the application filed under an intent-to-use basis. A second request for extension of time to file a Statement of Use has been granted, with the application now in the Intent to Use section.
Recent Activity
The application was filed on March 19, 2024, approved for publication on September 28, 2024, and published for opposition in the Official Gazette on Nov
Trademark Facts
| Mark | GENEXUS |
|---|---|
| Serial Number | 98456971 |
| Status | Pending |
| Filing Date | 2024-03-19 |
| Mark Type | Word |
| Nice Classes | 010 (Medical Devices) |
| Owner | Life Technologies Corporation |
| Attorney of Record | Kenya L. Williams |
| Prosecution Events | 21 |
| Latest Event | EXRA on 2025-12-17 |
Goods & Services
Apparatus and instruments for clinical and medical diagnosis, namely, nucleic acid sequencers and synthesizers, genetic analyzers, and instruments for the preparation of nucleic acid samples